StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.81+0.01 (+1.06%)

Close on Nov 17, 2026Market cap $104.43MP/E –Yield –

Organogenesis price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Organogenesis's price to book ratio was 0.9× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 0.7× to 6.3×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−1.7
2025Dec 31, 20252.6×+1.1
2024Dec 31, 20241.5×−0.4
2023Dec 29, 20231.9×+0.6
2022Dec 30, 20221.4×−4.9
2021Dec 31, 20216.3×−6.9
2020Dec 31, 202013.2×−22.4
2019Dec 31, 201935.6×−65.9
2018Jan 31, 2018101.5×+0.3
2017Dec 29, 2017101.1×–

More Organogenesis figures

See a number that looks wrong?